ALPX
NASDAQ:ALPX
Alopexx, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.alopexx.comipo date
Oct 07, 2022
Alopexx, Inc., a clinical stage biotechnology company, focusing on developing novel immune therapeutics for the prevention, treatment, and mitigation of bacterial, fungal, and parasitic infections. Its lead products include Vaccine AV0328, a synthetic poly N-acetyl glucosamine (PNAG) vaccine that has completed Phase I first-in-man trial for the treatment of streptococcus pneumo...Show More